Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...

The new Medicare GLP-1 Bridge program, which will allow seniors to get certain GLP-1 drugs for just $50 a month and is part ...

Medicare’s pilot program set to offer eligible Part D beneficiaries GLP-1 therapies for weight loss—read more.

GLP-1s aren’t a miracle weight-loss solution but a tool that facilitates behavior change and that comes with some significant ...

Trisha Paytas is opening up about her nutrition plan after going on a GLP-1 medication. “I have lost 30 pounds in two months ...

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The ...

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.